These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29211515)

  • 21. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A; Stadler J; Luecke E; Laborde N; Hartmann M; Montgomery ET;
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19146. PubMed ID: 25224610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes.
    Carlo Hojilla J; Koester KA; Cohen SE; Buchbinder S; Ladzekpo D; Matheson T; Liu AY
    AIDS Behav; 2016 Jul; 20(7):1461-9. PubMed ID: 25835463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Emotional stress is more detrimental than the virus itself": A qualitative study to understand HIV testing and pre-exposure prophylaxis (PrEP) use among internal migrant men in South Africa.
    Nardell MF; Govathson-Mandimika C; Garnier S; Watts A; Babalola D; Ngcobo N; Long L; Lurie MN; Miot J; Pascoe S; Katz IT
    J Int AIDS Soc; 2024 Mar; 27(3):e26225. PubMed ID: 38462755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland.
    Young I; Flowers P; McDaid LM
    BMJ Open; 2014 Nov; 4(11):e005717. PubMed ID: 25412863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "We are in this together:" dyadic-level influence and decision-making among HIV serodiscordant couples in Tanzania receiving access to PrEP.
    Fonner VA; Ntogwisangu J; Hamidu I; Joseph J; Fields J; Evans E; Kilewo J; Bailey C; Goldsamt L; Fisher CB; O'Reilly KR; Ruta T; Mbwambo J; Sweat MD
    BMC Public Health; 2021 Apr; 21(1):720. PubMed ID: 33853559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
    J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
    Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
    AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "You Never Know What Could Happen": Women's Perspectives of Pre-Exposure Prophylaxis in the Context of Recent Intimate Partner Violence.
    Willie TC; Keene DE; Kershaw TS; Stockman JK
    Womens Health Issues; 2020; 30(1):41-48. PubMed ID: 31537431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing risky sexual behaviour among Mozambican miners: a socio-epidemiological contribution for HIV prevention framework in Mozambique.
    Martins-Fonteyn E; Loquiha O; Baltazar C; Thapa S; Boothe M; Raimundo I; Hens N; Aerts M; Meulemans H; Degomme O; Wouters E
    Int J Equity Health; 2017 Oct; 16(1):179. PubMed ID: 29017564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Male partners' influence on women's acceptance and use of PrEP products across two high HIV-burdened districts in South Africa.
    Mbewe L; Govender E
    Afr J AIDS Res; 2020 Jul; 19(2):93-100. PubMed ID: 32320329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV testing, care, and treatment experiences among the steady male partners of female sex workers living with HIV in the Dominican Republic.
    Fleming PJ; Barrington C; Perez M; Donastorg Y; Kerrigan D
    AIDS Care; 2016; 28(6):699-704. PubMed ID: 27009379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives on biomedical HIV prevention options among women who inject drugs in Kenya.
    Bazzi AR; Yotebieng KA; Agot K; Rota G; Syvertsen JL
    AIDS Care; 2018 Mar; 30(3):343-346. PubMed ID: 28780885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A; Stadler J; Montgomery E; Hartmann M; Magazi B; Mathebula F; Schwartz K; Laborde N; Soto-Torres L
    PLoS One; 2014; 9(2):e89118. PubMed ID: 24586534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent stigmatizing and negative perceptions of pre-exposure prophylaxis (PrEP) users: implications for PrEP adoption among Latino men who have sex with men.
    Brooks RA; Nieto O; Landrian A; Donohoe TJ
    AIDS Care; 2019 Apr; 31(4):427-435. PubMed ID: 30021456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study.
    Franks J; Hirsch-Moverman Y; Loquere AS; Amico KR; Grant RM; Dye BJ; Rivera Y; Gamboa R; Mannheimer SB
    AIDS Behav; 2018 Apr; 22(4):1139-1149. PubMed ID: 29143163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
    Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
    AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
    AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding women and men's acceptability of current and new HIV prevention technologies in KwaZulu-Natal, South Africa.
    Govender E; Abdool Karim Q
    AIDS Care; 2018 Oct; 30(10):1311-1314. PubMed ID: 29914270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.